Comparative effectiveness is gaining momentum as a way to decide what drugs and devices should be used by doctors. But why was it part of the economic stimulus approved by Congress and pushed by President Obama? Dr. Les Paul, vice president of clinical and scientific affairs at the National Pharmaceutical Council, tells the Chicago Tribune's Bruce Japsen about how policymakers are looking at comparative effectiveness and how medical care providers and the healthcare industry should be involved.